Australian University Rankings Guide

Pediatrics International (ERA Journal)

Pediatrics International is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

Pediatrics International issns are issn1: 0001-6543 issn2: 1328-8067 issn3: 1442-200X.

The fields covered by Pediatrics International as part of the evaluation of Australian university research excellence are:

Medical Biochemistry and Metabolomics Research Rankings (Sub-Field)

Clinical Sciences Research Rankings (Sub-Field)

Paediatrics and Reproductive Medicine Research Rankings (Sub-Field)

Other ERA-accredited journals supporting the evaluation of the Medical Biochemistry and Metabolomics field include:

- BMC Medical Genomics
- Biomarkers in Medicine
- CPD Bulletin: Clinical Biochemistry
- Cellular and Molecular Biology
- Clinical Biochemistry
- Clinical Chemistry (Washington DC): international journal of molecular diagnostics and laboratory medicine
- Cold Spring Harbor Perspectives in Medicine
- Diabetes Metabolic Syndrome and Obesity: Targets and Therapy
- Drug Metabolism and Pharmacokinetics
- Growth Hormone and IGF Research
- International Journal of Tryptophan Research
- International Journal on Disability and Human Development
- Nature Reviews: Gastroenterology and Hepatology
- Prostaglandins and Other Lipid Mediators
- The Federation of European Biochemical Societies (FEBS) Journal


ERA Research Rankings Submenu


- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List



Latest News and Updates:


- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page

  • Share on Facebook1
  • Share on Twitter2
  • Share on Linkedin3
  • Share on Reddit4